Alamar Biosciences, Inc. (ALMR) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "ALMR"
      ],
      "issuer_cik": "0002104204",
      "owner_cik": "0002129671",
      "accession_number": "0001231919-26-001497",
      "form_type": "4",
      "filing_date": "2026-10-23",
      "period_of_report": "2026-10-21",
      "issuer_name": "Alamar Biosciences, Inc.",
      "issuer_trading_symbol": "ALMR",
      "owner_name": "Qiming GP VIII-HC, LLC",
      "is_director": false,
      "is_officer": false,
      "is_ten_percent_owner": true,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-10-22",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 99,
      "transaction_price_per_share": 30.81,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 172338,
      "transaction_value": 3050.19,
      "direct_or_indirect": "I",
      "nature_of_ownership": "See footnote",
      "footnotes": [
        {
          "id": "F10",
          "description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.41 to $31.23,\ninclusive."
        },
        {
          "id": "F2",
          "description": "These shares are held of record by Qiming Managing Directors Fund VI, L.P. (\"Qiming Managing Directors\"). Qiming Corporate GP VI, Ltd. (\"Qiming Corporate\") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."
        }
      ]
    },
    {
      "tickers": [
        "ALMR"
      ],
      "issuer_cik": "0002104204",
      "owner_cik": "0001733282",
      "accession_number": "0001231919-26-001497",
      "form_type": "4",
      "filing_date": "2026-10-23",
      "period_of_report": "2026-10-21",
      "issuer_name": "Alamar Biosciences, Inc.",
      "issuer_trading_symbol": "ALMR",
      "owner_name": "Qiming Managing Directors Fund VI, L.P.",
      "is_director": false,
      "is_officer": false,
      "is_ten_percent_owner": true,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-10-22",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 10319,
      "transaction_price_per_share": 29.59,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 1790212,
      "transaction_value": 305339.21,
      "direct_or_indirect": "I",
      "nature_of_ownership": "See footnote",
      "footnotes": [
        {
          "id": "F9",
          "description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.36 to $30.33,\ninclusive."
        },
        {
          "id": "F7",
          "description": "These shares are held of record by Qiming Venture Partners VIII-HC, L.P. (\"QVP VIII-HC\"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.